Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Kjekshus

Showing results (31-40 of 112) with videos related to

Pageof 12
Sort By:
Journal of the American College of Cardiology|July 27, 2002
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)John Wikstrand, Ake Hjalmarson, Finn Waagstein, et al.
International Journal of Cardiology|October 21, 2006
Impact of neurohormonal blockade on association between body mass index and mortalityLinn M A Kennedy, Stefan D Anker, John Kjekshus, et al.
The American Journal of Cardiology|January 28, 2010
Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphomaRune Andersen, Torgeir Wethal, Anne Günther, et al.
Atherosclerosis|January 7, 2009
Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S)Janna Huskey, Joann Lindenfeld, Thomas Cook, et al.
Circulation|March 13, 2002
Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)Stephen S Gottlieb, Michael L Fisher, John Kjekshus, et al.
American Heart Journal|October 31, 2006
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarctionMette Elise Estensen, Aina Hognestad, Unni Syversen, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
Lancet (London, England)|September 1, 2004
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)Timo E Strandberg, Kalevi Pyörälä, Thomas J Cook, et al.
European Heart Journal|February 18, 2005
Soluble CD40 ligand in acute and chronic heart failureThor Ueland, Pål Aukrust, Arne Yndestad, et al.
Pageof 12

Showing results (31-40 of 112) with videos related to

Sort By:
Pageof 12
Journal of the American College of Cardiology|July 27, 2002
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)John Wikstrand, Ake Hjalmarson, Finn Waagstein, et al.
International Journal of Cardiology|October 21, 2006
Impact of neurohormonal blockade on association between body mass index and mortalityLinn M A Kennedy, Stefan D Anker, John Kjekshus, et al.
The American Journal of Cardiology|January 28, 2010
Relation of coronary artery calcium score to premature coronary artery disease in survivors >15 years of Hodgkin's lymphomaRune Andersen, Torgeir Wethal, Anne Günther, et al.
Atherosclerosis|January 7, 2009
Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S)Janna Huskey, Joann Lindenfeld, Thomas Cook, et al.
Circulation|March 13, 2002
Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)Stephen S Gottlieb, Michael L Fisher, John Kjekshus, et al.
American Heart Journal|October 31, 2006
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarctionMette Elise Estensen, Aina Hognestad, Unni Syversen, et al.
Journal of the American College of Cardiology|December 6, 2005
Plasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsThor Ueland, John Kjekshus, Stig S Frøland, et al.
European Heart Journal. Acute Cardiovascular Care|February 25, 2014
The Seattle Post Myocardial Infarction Model (SPIM): prediction of mortality after acute myocardial infarction with left ventricular dysfunctionEric S Ketchum, Kenneth Dickstein, John Kjekshus, et al.
Lancet (London, England)|September 1, 2004
Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S)Timo E Strandberg, Kalevi Pyörälä, Thomas J Cook, et al.
European Heart Journal|February 18, 2005
Soluble CD40 ligand in acute and chronic heart failureThor Ueland, Pål Aukrust, Arne Yndestad, et al.
Pageof 12